FIELD: medicine.
SUBSTANCE: invention refers to medicine, and aims at assessing the probability of an unfavorable outcome in the patients suffering pulmonary arterial hypertension (PAH) associated with systemic connective tissue diseases (SCTD). A uric acid level (X1), concentration of C-reactive protein (X2) and presence of anticentromere antibodies (X3); wherein X1 and X3 is evaluated in points, namely: with value X1≥435 mcmole/l, assigning "1 point", with value of <435 mcmole/l, assigning "0 points", in the absence of X3 assigning "0 points", in the presence of X3 – "1 point"; X2 – in absolute values, g/l; based on obtained data determining probability of adverse outcome of PAH SCTD (p) by formula: p=0.1624×exp(1.4103×X1+0.0365×X2+1.0636×X3), if p<0.5, a low risk of an unfavorable outcome is stated if 0.5≤p<0.7, the average risk of an unfavorable outcome is determined, in the cases p≥0.7, high risk of adverse outcome of PAH associated with SCTD.
EFFECT: method enables higher diagnostic accuracy.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INVASIVE DIAGNOSIS OF LEFT VENTRICULAR PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC CONNECTIVE TISSUE DISEASES WITH NORMAL PULMONARY ARTERY OCCLUSIVE PRESSURE | 2019 |
|
RU2720823C1 |
METHOD FOR PREDICTION OF THE RISK OF DEVELOPING ATHEROSCLEROTIC INVOLVEMENT OF CAROTID ARTERIES IN PATIENTS SUFFERING SYSTEMIC LUPUS ERYTHEMATOSUS | 2020 |
|
RU2736610C1 |
METHOD FOR RAPID ASSESSMENT OF AXIAL SKELETON INVOLVEMENT RISK IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2724276C1 |
CALCULATION OF INDIVIDUAL RISK OF TYPE 2 DIABETES IN PATIENTS WITH GOUT | 2022 |
|
RU2798778C1 |
METHOD FOR ASSESSING THE RISK OF JOINT EROSIONS IN PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2791661C1 |
AGENT FOR TREATING PULMONARY HYPERTENSION | 2023 |
|
RU2813890C1 |
METHOD FOR PREDICTING AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2021 |
|
RU2769488C1 |
METHOD FOR EARLY PREDICTION OF LONG-TERM OUTCOME OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2021 |
|
RU2795193C1 |
METHOD FOR ASSESSING THE RISK OF HOSPITAL MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROME FOLLOWING A PERCUTANEOUS CORONARY INTERVENTION | 2019 |
|
RU2734993C1 |
METHOD FOR MULTIFACTOR PREDICTION OF REMOTE UNFAVOURABLE OUTCOMES IN PATIENTS SUFFERED ACUTE CORONARY SYNDROME WITH PERSISTENT ST-SEGMENT ELEVATION | 2014 |
|
RU2566212C1 |
Authors
Dates
2019-12-19—Published
2019-10-18—Filed